DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award
About This Opportunity
United States procurement, healthcare: DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea. Issued by Dept. Submission deadline Sep 2026.
This is a grants contract in the health and medical services and Research sectors, with a focus on Pharmaceuticals and Innovation. Located in United States, North America, this opportunity is open to firms and consortiums. Proposals must be submitted before September 30, 2026.
Published through Grants.gov, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for grants in the health and medical services sector. Grant applications generally require a detailed project proposal, a clear results framework, and evidence of the applicant's capacity to deliver the proposed activities. Interested parties should review the full documentation on the original source before submitting their proposal.
Description
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Idea Award (TIA) supports new, innovative, high-risk, high-gain ideas aimed at amyotrophic lateral sclerosis (ALS) drug or therapy discovery. The studies supported by this award mechanism are expected to be hypothesis-driven and generate preliminary data for future avenues of therapeutic investigation.
Distinctive Features: Potential impact and innovation are important features of the TIA. Applications may demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis. While the inclusion of preliminary data is not prohibited, the strength of the application should rely on the approach.
Agency: Jamie Shortall
Grant Officer
CFDA: 12.420
Applicant Types: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Cost Sharing: No
Contact: Jamie Shortall
Grant Officer
Email: help@eBRAP.org
Data provenance
This notice is sourced from Grants.gov and was originally published on May 4, 2026. Last refreshed 5 days ago. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Dept. of the Army -- USAMRAA
Dept. of the Army -- USAMRAA has issued 77 procurement notices on BidsFactory, including 77 currently open and 0 awarded contracts. Activity concentrates in Health & Medical, Research & Innovation, and Information & Communication Technology. All notices are published for United States. Notices are distributed via Grants.gov. Most recent publication: June 17, 2026.
Frequently asked questions about this tender
How can I submit a bid?
Visit Grants.gov to access the full notice, required documents, and submission instructions provided by the contracting authority.
When does this tender close?
The submission deadline is September 30, 2026. You have 96 days left to prepare and submit your proposal to the contracting authority.
Who is the contracting authority?
This notice was issued by Dept. of the Army -- USAMRAA in United States. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Grants contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
Where will the contract be performed?
The contract is for delivery in United States. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.
Sectors & Categories
Key Details
Contracting Authority
Contact
Companies That Won Similar
Companies with awards in Health & Medical in United States